BNP Paribas Financial Markets
SPRB

BNP Paribas Financial Markets’s Spruce Biosciences SPRB Stock Holding History

BNP Paribas Financial Markets’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5K Buy
+453
New +$25.3K ﹤0.01% 5187
2026
Q1 		– Sell
-2,000
Closed -$174K – 6195
2025
Q4 		$174K Buy
+2,000
New +$214K ﹤0.01% 4109
2025
Q2 		– Sell
-2
Closed -$52 – 5724
2025
Q1 		$52 Hold
2
– – ﹤0.01% 5291
2024
Q4 		$76 Buy
+2
New +$73 ﹤0.01% 5297

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

BNP Paribas Financial Markets's SPRB Position: Q2 2026 in Review

BNP Paribas Financial Markets opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 453 shares worth $24.5K. The stake represents ﹤0.01% of the portfolio and ranks #5187 among its holdings. This is a return to the name: BNP Paribas Financial Markets previously reported a position in SPRB as recently as Q4 2025.

BNP Paribas Financial Markets first reported a position in SPRB in Q4 2024 and has held it in 4 quarters since. The position peaked at $174K in Q4 2025. 57 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • BNP Paribas Financial Markets held 453 shares of Spruce Biosciences worth $24.5K as of Q2 2026.
  • Spruce Biosciences was a new BNP Paribas Financial Markets position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5187 holding.
  • BNP Paribas Financial Markets first reported a position in Spruce Biosciences in Q4 2024 and has held it in 4 quarters since.
  • BNP Paribas Financial Markets's Spruce Biosciences position peaked at $174K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.